In addition, gliomas release immunosuppressant cytokines such as TGF-β, IL-10 and cyclooxygenase 2 (COX-2), while simultaneously inhibiting signal transducer and activator of transcription 3 (STAT3), thus enhancing the immunosuppressive microenvironment [21]. The gene discussed is TGFB1; the disease is central nervous system cancer.